Inhibikase Therapeutics (IKT) null Earnings

16AugConfirmed
Dec 20
Mar 21
May 21
Aug 21
-0.38
-0.25
-0.13
0

Details

Expected EPS
-0.38
Actual EPS
-0.22
Surprise EPS
0.16
Surprise Percent
+42.11%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.22 per share for .

0 Comments

Share your thoughts